Novo Holdings A/S - 18 Mar 2024 Form 4 Insider Report for SPRUCE BIOSCIENCES, INC. (SPRB)

Role
10%+ Owner
Signature
/s/ Barbara Fiorini Due, General Counsel, Finance & Operations
Issuer symbol
SPRB
Transactions as of
18 Mar 2024
Net transactions value
-$1,358,804
Form type
4
Filing time
20 Mar 2024, 20:56:02 UTC
Previous filing
18 Mar 2024
Next filing
25 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SPRB COMMON STOCK Sale $647,008 -842,020 -18% $0.7684* 3,968,000 18 Mar 2024 Direct F1
transaction SPRB COMMON STOCK Sale $447,715 -593,000 -15% $0.7550* 3,375,000 19 Mar 2024 Direct F2
transaction SPRB COMMON STOCK Sale $264,081 -359,979 -11% $0.7336* 3,015,021 20 Mar 2024 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.75 to $0.8004, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.7105 to $0.7887, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.7110 to $0.7633, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.